$PFSA News

Profusa Receives ISO 13485:2016 Certificate from GMED

Profusa Secures Its ISO 13485:2016 Certificate From EU MDR Notified Body, GMED, Covering Lumee Oxygen Platform

Profusa ISO 13485 Certification Decision Advances Lumee Oxygen Platform Toward CE Mark

Micro Cap Profusa Navigates European Regulatory Hurdles to Advance Oxygen Monitoring Tech

Profusa, Inc. Receives Nasdaq Compliance Determination

Profusa Receives Nasdaq Letter Indicating Compliance; Company Remains Subject To A One-Year Mandatory Panel Monitor

Profusa, Inc. Announces Compliance with Nasdaq Publicly Held Shares Requirement

Profusa Regains Nasdaq Compliance

Profusa Advances G3 Vision Labs Acquisition Conditions as Q2 Net Loss Widens

Profusa Announces Q2 2026 Financial Results and Progress on the Option Agreement Conditions to Close with G3 Vision Labs, a Commercial Stage Diagnostics Company

Profusa Q2 EPS $(151.80) Up From $(9.10 thousand) YoY

Profusa Stock Dips After Hours As Whopping 506% Rally Cools: Here Is Why PFSA Is Trending

Profusa Announces 1-for-4 Reverse Stock Split

Profusa vies for potential G3 Vision Labs acquisition

Profusa Announces Signing of Option Agreement for the Acquisition of a Commercial Stage Diagnostics Company, G3 Vision Labs

Profusa Enters Option Agreement To Buy G3 Vision Labs And Affiliates; Has Right To Buy 100% Of G3 Vision Labs

Profusa Signs Term Sheet for Diagnostics Acquisition and Announces Leadership Changes

Profusa Announces Key Management Changes and Signing of Non-Binding Term Sheet for the Acquisition of a Commercial Stage Diagnostics Company

Why Is Profusa Stock Falling Monday?

Profusa To Merge With Privately Held, Commercial-Stage Health Diagnostics And Toxicology Testing Company; Profusa To Issue 19.99% Stake to The Company And Will Issue Convertible Prefs; Combined Entity Operate As Public Diagnostics Firm